Patents by Inventor Yanqiu Chen

Yanqiu Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230273224
    Abstract: An application method of at least one of a THBS1 protein and a THBS3 protein as biomarkers for detecting acute myocardial infarction is provided, which belongs to the field of biomedical technology. The THBS1 protein and THBS3 protein in peripheral plasma are low expressed in patients with acute myocardial infarction through proteomic results, the proteomic results are verified by expanding the number of patients’ samples, and the two proteins can be used as molecular markers for the diagnosis of acute myocardial infarction. It has the advantages that: (1) peripheral blood samples are easy to obtain, saving time and labor; (2) the experiment is simple and easy to operate; (3) a new intervention target for diagnosis and treatment of acute myocardial infarction is found; (4) a new direction is provided for treating acute myocardial infarction and improving prognosis in the future; and (5) a new idea is provided for precision medicine.
    Type: Application
    Filed: October 28, 2022
    Publication date: August 31, 2023
    Inventors: Heyu Meng, Jianjun Ruan, Fanbo Meng, Yanqiu Chen, Zhaohan Yan
  • Publication number: 20040157775
    Abstract: This invention comprises antibodies to rapamycin effector proteins, and preparations thereof. Novel Rapamycin-FKBP12 binding proteins, nucleic acids and their fragments are also described, as are related methods and therapeutic uses of the proteins, nucleic acids, and antibodies.
    Type: Application
    Filed: October 15, 2003
    Publication date: August 12, 2004
    Applicants: Wyeth, The Trustees of Columbia University
    Inventors: Thomas J. Caggiano, Yanqiu Chen, Amedeo A. Failli, Katherine L. Molnar-Kimber, Koji Nakanishi
  • Patent number: 6713607
    Abstract: This invention comprises novel Rapamycin-FKBP12 binding proteins of mammalian origin for identification, design and synthesis of immunomodulatory, anti-restenosis or anti-tumor agents, as well as fragments of the proteins and the DNA, cDNA, antisense RNA and DNA segments corresponding to the proteins. This invention also comprises methods for isolating the proteins and therapeutic uses related to the proteins.
    Type: Grant
    Filed: September 13, 2001
    Date of Patent: March 30, 2004
    Assignee: Wyeth
    Inventors: Thomas J. Caggiano, Yanqiu Chen, Amedeo A. Failli, Katherine L. Molnar-Kimber, Koji Nakanishi
  • Publication number: 20030032775
    Abstract: This invention comprises novel Rapamycin-FKBP12 binding proteins of mammalian origin for identification, design and synthesis of immunomodulatory, anti-restenosis or anti-tumor agents, as well as fragments of the proteins and the DNA, cDNA, antisense RNA and DNA segments corresponding to the proteins. This invention also comprises methods for isolating the proteins and therapeutic uses related to the proteins.
    Type: Application
    Filed: September 13, 2001
    Publication date: February 13, 2003
    Applicant: American Home Products
    Inventors: Thomas J. Caggiano, Yanqiu Chen, Amedeo A. Failli, Katherine L. Molnar-Kimber, Koji Nakanishi
  • Patent number: 6313264
    Abstract: This invention comprises novel Rapamycin-FKBP12 binding proteins of mammalian origin for identification, design and synthesis of immunomodulatory, anti-restenosis or anti-tumor agents, as well as fragments of the proteins and the DNA, cDNA, antisense RNA and DNA segments corresponding to the proteins. This invention also comprises methods for isolating the proteins and therapeutic uses related to the proteins.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: November 6, 2001
    Assignees: American Home Products Corporation, The Trustees of Columbia University
    Inventors: Thomas J. Caggiano, Yanqiu Chen, Amedeo A. Failli, Katherine L. Molnar-Kimber, Koji Nakanishi